The Enterprise Value as of December 2025 (TTM) for Recro Pharma, Inc. (REPH) is 189.40M

According to Recro Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 189.40M. This represents a change of 62.84% compared to the average of 116.31M of the last 4 quarters.

Recro Pharma, Inc. (REPH) Historical Enterprise Value (quarterly & annually)

How has REPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Recro Pharma, Inc. over the last ten years is 144.71M. The current 189.40M Enterprise Value has changed 12.99% with respect to the historical average. Over the past ten years (40 quarters), REPH's Enterprise Value was at its highest in in the December 2019 quarter at 512.56M. The Enterprise Value was at its lowest in in the March 2014 quarter at -18408100.73.

Recro Pharma, Inc. (REPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Recro Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Recro Pharma, Inc. (REPH) Average Enterprise Value

How has REPH Enterprise Value performed in the past?

The current Enterprise Value of Recro Pharma, Inc. (REPH) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Recro Pharma, Inc. (REPH) Enterprise Value vs. Peers

How is REPH’s Enterprise Value compared to its peers?

Recro Pharma, Inc.’s Enterprise Value is greater than Theratechnologies Inc. (183.50M), greater than Theseus Pharmaceuticals, Inc. (90.87M), greater than BioSig Technologies, Inc. (180.09M), less than LENZ Therapeutics, Inc. (469.74M), greater than Shineco, Inc. (11.67M), less than LakeShore Biopharma Co., Ltd (624.47M), greater than Vaccitech plc (-34608760.00), less than Zevra Therapeutics, Inc. (484.06M), greater than F-star Therapeutics, Inc. (91.20M), less than Procaps Group S.A. (345.02M),

Build a custom stock screener for Recro Pharma, Inc. (REPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recro Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Recro Pharma, Inc. (REPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Recro Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.